id,group_id,source,exact,prefix,suffix,anno_type,position_type,start,end,tags,all,origin_tags,comment,user,title,created
zIDP8MrcEem9uVdgzAvKhg,jgraPEon,https://europepmc.org/articles/PMC5486778/,NK/TCL,ed in the studyTotalHLB-NHLT-NHL,DLBCLOthers(n = 174)(n = 18)(n =,TextQuoteSelector,TextPositionSelector,12874,12880,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-30T04:15:28.224782+00:00
xhyNBL5LEemlimO1IP6IPg,jgraPEon,https://europepmc.org/articles/PMC5486778/, colorectal cancer,"er studies on breast tumors [9],"," [10], lung cancer [11], and oth",TextQuoteSelector,TextPositionSelector,10578,10596,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:27:06.445399+00:00
wlcJrL5PEemmGl-UOuVq5g,jgraPEon,https://europepmc.org/articles/PMC5486778/,infection,"n increase in ccfDNA, including ", or chemotherapy drug-induced re,TextQuoteSelector,TextPositionSelector,33590,33599,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:55:38.037043+00:00
veh89L5mEemX-Wed-WqCkw,jgraPEon,https://europepmc.org/articles/PMC5486778/,Hodgkin’s lymphoma,"dowData were presented as n
HL, ","; B-NHL, B cell non-Hodgkin’s ly",TextQuoteSelector,TextPositionSelector,13380,13398,WS_DS,yes,[WS_DS][ALL],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T07:40:09.042529+00:00
v4AOsL5SEemESg-wbSvifg,jgraPEon,https://europepmc.org/articles/PMC5486778/,lactate dehydrogenase,"dvanced stage disease, elevated "," levels, and a higher prognosis ",TextQuoteSelector,TextPositionSelector,8733,8754,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T05:17:01.830338+00:00
u6e1aMrcEemdmRcusbbuiQ,jgraPEon,https://europepmc.org/articles/PMC5486778/,NK/TCL, extranodal NK/T cell lymphoma (,"), respectively. The diagnosis o",TextQuoteSelector,TextPositionSelector,12392,12398,"WT_GP,DS",yes,[WT_GP][DS][ALL],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-30T04:14:59.829181+00:00
tWMzFL5LEemdZnfrtzUyJg,jgraPEon,https://europepmc.org/articles/PMC5486778/,breast tumors,s confirmed by other studies on ," [9], colorectal cancer [10], lu",TextQuoteSelector,TextPositionSelector,10560,10573,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:26:38.468927+00:00
tTkJ0r5PEemtrRNPOHfUjA,jgraPEon,https://europepmc.org/articles/PMC5486778/,autoimmune diseases, identified in inflammatory and ,. An association between a high ,TextQuoteSelector,TextPositionSelector,33268,33287,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:55:16.119868+00:00
rhsYEr5OEem_8dcP6LSbmg,jgraPEon,https://europepmc.org/articles/PMC5486778/,chronic lymphocytic leukemia,"lymphoma, 7 small cell lymphoma/",", 6 marginal zone lymphoma, 5 ma",TextQuoteSelector,TextPositionSelector,13543,13571,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:47:54.591748+00:00
qlpjGr5qEemOqWcbVemWBg,jgraPEon,https://europepmc.org/articles/PMC5486778/,amyloid beta precursor protein, amplification of the APP gene (,", chromosome 21q21.3, accession ",TextQuoteSelector,TextPositionSelector,15636,15666,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T08:08:14.346748+00:00
qixxTr5MEemlkBMGeOfjBA,jgraPEon,https://europepmc.org/articles/PMC5486778/,B-NHL,nts included in the studyTotalHL,T-NHLNK/TCLDLBCLOthers(n = 174)(,TextQuoteSelector,TextPositionSelector,12864,12869,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:33:28.946746+00:00
qRa2GL5PEemqD685Jp80XQ,jgraPEon,https://europepmc.org/articles/PMC5486778/,Epstein-Barr virus ,y lymphoma-specific DNA such as ,DNA could be used to monitor the,TextQuoteSelector,TextPositionSelector,31657,31676,CRT_OG,no,CRT_OG,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:54:55.644114+00:00
o6YKFr5LEemqKFO4NvlSzA,jgraPEon,https://europepmc.org/articles/PMC5486778/,malignant tumors,a potential biomarker to detect ,. A study by Leon et al. [8] sug,TextQuoteSelector,TextPositionSelector,10318,10334,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:26:08.415380+00:00
o4VRDL5mEemvPf_307lrow,jgraPEon,https://europepmc.org/articles/PMC5486778/,B cell non-Hodgkin’s lymphoma,"
HL, Hodgkin’s lymphoma; B-NHL, ","; DLBCL, diffuse large B cell ly",TextQuoteSelector,TextPositionSelector,13407,13436,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T07:39:24.756489+00:00
lfgmcL5PEemQ6otqyGzc0Q,jgraPEon,https://europepmc.org/articles/PMC5486778/, tumor,levels of ctDNA could assess the, response and even provide an ea,TextQuoteSelector,TextPositionSelector,34406,34412,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:54:23.659606+00:00
kFugvr5qEemKks-4mYA8mQ,jgraPEon,https://europepmc.org/articles/PMC5486778/,APP," shorter DNA fragments, for the ", gene was detected using real-ti,TextQuoteSelector,TextPositionSelector,8421,8424,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T08:07:30.570553+00:00
j-JZ0r5nEemoY3sNzO0ufQ,jgraPEon,https://europepmc.org/articles/PMC5486778/,Burkitt lymphoma,"a, 5 mantle cell lymphoma and 1 ","; T-NHL, T cell non-Hodgkin’s ly",TextQuoteSelector,TextPositionSelector,13628,13644,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T07:46:01.356621+00:00
izxCLL5NEem_6Ts3M1vLIQ,jgraPEon,https://europepmc.org/articles/PMC5486778/,NHL , HL patients were as high as in ,patients and indicated that the ,TextQuoteSelector,TextPositionSelector,33914,33918,"WT_GP,DS",no,[WT_GP][DS],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:39:46.569593+00:00
gYk34r5PEemqPxPqV9nCiA,jgraPEon,https://europepmc.org/articles/PMC5486778/,malignancies,"y, studies conducted in various ", have shown that ccfDNA levels a,TextQuoteSelector,TextPositionSelector,28966,28978,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:53:49.326231+00:00
fwetNr5LEemp-xMPYIEHYg,jgraPEon,https://europepmc.org/articles/PMC5486778/,myocardial infarction,"ne disease [5], trauma [6], and "," [7]. Recently, quantifying ccfD",TextQuoteSelector,TextPositionSelector,10202,10223,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:25:07.138105+00:00
flEgxL5MEemfHYOgaeLhrQ,jgraPEon,https://europepmc.org/articles/PMC5486778/,B-NHL,re B cell non-Hodgkin lymphoma (,"), with diffuse large B cell lym",TextQuoteSelector,TextPositionSelector,12194,12199,"WT_GP,DS",yes,[WT_GP][DS][ALL],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:32:15.573853+00:00
fMYdgr5fEemaNdsbNBGKog,jgraPEon,https://europepmc.org/articles/PMC5486778/,HL, and 21 patients diagnosed with ,", T cell non-HL (T-NHL), and ext",TextQuoteSelector,TextPositionSelector,12330,12332,MIS_DS,yes,[MIS_DS][ALL],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T06:48:13.422975+00:00
duM_gr5nEemqk8cNgDaciw,jgraPEon,https://europepmc.org/articles/PMC5486778/,mantle cell lymphoma,"ia, 6 marginal zone lymphoma, 5 "," and 1 Burkitt lymphoma; T-NHL, ",TextQuoteSelector,TextPositionSelector,13601,13621,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T07:45:19.389675+00:00
dTDIJL5LEemfFivUQww04Q,jgraPEon,https://europepmc.org/articles/PMC5486778/,trauma ,"se [4], autoimmune disease [5], ","[6], and myocardial infarction [",TextQuoteSelector,TextPositionSelector,10186,10193,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:24:50.608747+00:00
bEC-mr5kEemlzdsJ5FAY8w,jgraPEon,https://europepmc.org/articles/PMC5486778/,extranodal NK/T cell lymphoma ," HL, T cell non-HL (T-NHL), and ","(NK/TCL), respectively. The diag",TextQuoteSelector,TextPositionSelector,12361,12391,WS_DS,yes,[WS_DS][ALL],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T07:23:33.092160+00:00
_NcZer5SEem5w0tatjHuug,jgraPEon,https://europepmc.org/articles/PMC5486778/,diffuse large B cell lymphoma,ognosis score. In patients with ," (DLBCL), high levels of ccfDNA ",TextQuoteSelector,TextPositionSelector,8810,8839,WS_DS,yes,[WS_DS][ALL],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T05:18:44.713157+00:00
_4_1kL5KEemHof-hRalILg,jgraPEon,https://europepmc.org/articles/PMC5486778/,cancer ,haracteristics and prognosis of ,patients. Our objective was to a,TextQuoteSelector,TextPositionSelector,7966,7973,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:21:33.249202+00:00
_1QPRsrcEem63ctHYbt1NQ,jgraPEon,https://europepmc.org/articles/PMC5486778/,non-Hodgkin’s lymphoma,core was used for patients with , and the IPS score for patients ,TextQuoteSelector,TextPositionSelector,25442,25464,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-30T04:16:53.489895+00:00
YCx4jr5PEemlhIcfc6t7Ww,jgraPEon,https://europepmc.org/articles/PMC5486778/,LDH,.571 (0.133–2.456)0.452Elevated ,"4.545 (1.522–13.57)
0.007
Elevat",TextQuoteSelector,TextPositionSelector,28259,28262,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:52:53.377874+00:00
XHliLL5MEemfG2vUVaMOcw,jgraPEon,https://europepmc.org/articles/PMC5486778/,B cell non-Hodgkin lymphoma,"cluded lymphoma cases, 126 were "," (B-NHL), with diffuse large B c",TextQuoteSelector,TextPositionSelector,12165,12192,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:31:18.605802+00:00
Wauqor5PEemwp-NmgIextQ,jgraPEon,https://europepmc.org/articles/PMC5486778/,LDH,ase (stage IIB–IV) and elevated , levels were associated with inc,TextQuoteSelector,TextPositionSelector,23095,23098,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:52:42.422971+00:00
W3kTwL5nEemqklswO2Pp5g,jgraPEon,https://europepmc.org/articles/PMC5486778/,marginal zone lymphoma,"chronic lymphocytic leukemia, 6 ",", 5 mantle cell lymphoma and 1 B",TextQuoteSelector,TextPositionSelector,13575,13597,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T07:44:33.396351+00:00
VngGAr5NEemaB6-eRxUgkA,jgraPEon,https://europepmc.org/articles/PMC5486778/,T-NHL,"agnosed with HL, T cell non-HL (","), and extranodal NK/T cell lymp",TextQuoteSelector,TextPositionSelector,12349,12354,"WT_GP,DS",yes,[WT_GP][DS][ALL],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:38:18.171766+00:00
UkqY_L5qEemX_FviPXJU5Q,jgraPEon,https://europepmc.org/articles/PMC5486778/,angioimmunoblastic T cell lymphoma,"aplastic large-cell lymphoma, 2 ","; NK/TCL, extranodal NK/T cell l",TextQuoteSelector,TextPositionSelector,13762,13796,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T08:05:46.475246+00:00
USFtTr5LEemNt5tJR4OZzg,jgraPEon,https://europepmc.org/articles/PMC5486778/,autoimmune disease,"ed in inflammatory disease [4], "," [5], trauma [6], and myocardial",TextQuoteSelector,TextPositionSelector,10162,10180,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:23:50.083637+00:00
OT_r7L5LEemXgaf2hjps4A,jgraPEon,https://europepmc.org/articles/PMC5486778/, inflammatory disease,of ccfDNA has been identified in," [4], autoimmune disease [5], tr",TextQuoteSelector,TextPositionSelector,10135,10156,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:23:10.079896+00:00
OAVTVr5qEemKkXeTaixrog,jgraPEon,https://europepmc.org/articles/PMC5486778/,T cell non-Hodgkin’s lymphoma," and 1 Burkitt lymphoma; T-NHL, ",", included in 4 peripheral T cel",TextQuoteSelector,TextPositionSelector,13653,13682,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T08:05:02.405479+00:00
NiLZwr5NEemELiMjYStzaw,jgraPEon,https://europepmc.org/articles/PMC5486778/,T-NHL,ncluded in the studyTotalHLB-NHL,NK/TCLDLBCLOthers(n = 174)(n = 1,TextQuoteSelector,TextPositionSelector,12869,12874,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:37:23.805486+00:00
Mq8YzL5nEemOH6MgErZ9Iw,jgraPEon,https://europepmc.org/articles/PMC5486778/,small cell lymphoma,"cluded 9 follicular lymphoma, 7 ","/chronic lymphocytic leukemia, 6",TextQuoteSelector,TextPositionSelector,13523,13542,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T07:43:24.892348+00:00
LABUnr5QEempLBfRavg0QQ,jgraPEon,https://europepmc.org/articles/PMC5486778/,mycobacterium tuberculosis,bead method in the detection of , DNA and found that the magnetic,TextQuoteSelector,TextPositionSelector,35574,35600,"WT_DS,OG",no,[WT_DS][OG],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:58:35.324716+00:00
J4o5dr5PEem5rDuLgQyRsg,jgraPEon,https://europepmc.org/articles/PMC5486778/,human,ons (2 × 10−1−2 × 105 ng/ml) of ," genomic DNA (Promega, Madison, ",TextQuoteSelector,TextPositionSelector,16953,16958,CRT_OG,no,CRT_OG,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:51:18.313379+00:00
IkuPjL5PEemHne_HwrUN3g,jgraPEon,https://europepmc.org/articles/PMC5486778/,Human ,d the study was approved by the ,Research Ethics Committee of the,TextQuoteSelector,TextPositionSelector,14167,14173,WT_OG,no,[WT_OG],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:51:09.570880+00:00
HveX1L5qEemKCe8vXJuaVQ,jgraPEon,https://europepmc.org/articles/PMC5486778/,peripheral T cell lymphoma,"dgkin’s lymphoma, included in 4 ",", 3 anaplastic large-cell lympho",TextQuoteSelector,TextPositionSelector,13698,13724,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T08:04:20.405019+00:00
Hr2HZr5LEemu1EMPFQcgFw,jgraPEon,https://europepmc.org/articles/PMC5486778/,lymphoma ,ncluded plasma samples from 174 ,patients and 80 healthy individu,TextQuoteSelector,TextPositionSelector,8200,8209,MIS_DS,yes,[MIS_DS][ALL],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:22:25.718245+00:00
GTjV1L5LEemu05_2G9u2kw,jgraPEon,https://europepmc.org/articles/PMC5486778/,lymphoma,tic prediction in patients with ,: a single-center experienceMao ,TextQuoteSelector,TextPositionSelector,5980,5988,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:22:16.440092+00:00
G3fqvr5MEemxy7NOEFZ2Qw,jgraPEon,https://europepmc.org/articles/PMC5486778/,lymphoproliferative diseases,few reports regarding ccfDNA in ,. It has been hypothesized that ,TextQuoteSelector,TextPositionSelector,11425,11453,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:29:29.577524+00:00
E8l1Br5TEemHCHeomQIBVQ,jgraPEon,https://europepmc.org/articles/PMC5486778/,DLBCL, diffuse large B cell lymphoma (,"), high levels of ccfDNA (both c",TextQuoteSelector,TextPositionSelector,8841,8846,MIS_DS,yes,[MIS_DS][ALL],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T05:19:23.016255+00:00
DoU7osrdEemMcgcsuEtLMg,jgraPEon,https://europepmc.org/articles/PMC5486778/,solid tumors,equate surrogate biomarker. For ,", many studies have validated th",TextQuoteSelector,TextPositionSelector,34244,34256,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-30T04:17:18.754995+00:00
CwKsXr5NEemNwVMm32FRNA,jgraPEon,https://europepmc.org/articles/PMC5486778/,T cell non-HL," 21 patients diagnosed with HL, "," (T-NHL), and extranodal NK/T ce",TextQuoteSelector,TextPositionSelector,12334,12347,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:36:11.496909+00:00
CYtOGL5MEemqAm_8nOgfXQ,jgraPEon,https://europepmc.org/articles/PMC5486778/,cancers, was increased in patients with , [14–16].Although the presence o,TextQuoteSelector,TextPositionSelector,11285,11292,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:28:59.554590+00:00
BPqmRL5nEemoYZsMxHi6zQ,jgraPEon,https://europepmc.org/articles/PMC5486778/,follicular lymphoma,mphoma; Others group included 9 ,", 7 small cell lymphoma/chronic ",TextQuoteSelector,TextPositionSelector,13500,13519,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T07:42:08.283329+00:00
AQdO2L5PEemQ5edbHuXHjQ,jgraPEon,https://europepmc.org/articles/PMC5486778/,IPS,international prognostic index; ,", international prognostic score",TextQuoteSelector,TextPositionSelector,13874,13877,WT_GP,yes,[WT_GP][ALL],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:50:13.837762+00:00
6wZWar5OEemHnDv53AhMHg,jgraPEon,https://europepmc.org/articles/PMC5486778/,anaplastic large-cell lymphoma,"4 peripheral T cell lymphoma, 3 ",", 2 angioimmunoblastic T cell ly",TextQuoteSelector,TextPositionSelector,13728,13758,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:49:36.944744+00:00
5wBb9L5LEem33m9BJEVuyA,jgraPEon,https://europepmc.org/articles/PMC5486778/,necrotic tumor ,"tic cells, ccfDNA released from ","cells varies in size, which may ",TextQuoteSelector,TextPositionSelector,10922,10937,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:28:01.681973+00:00
5b2Hwr5PEem__iMEhO0Row,jgraPEon,https://europepmc.org/articles/PMC5486778/,tumor,rdant with those of the primary ,. This may explain why our data ,TextQuoteSelector,TextPositionSelector,33815,33820,WS_DS,yes,[WS_DS][ALL],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:56:37.318350+00:00
40qIDL5NEemqC8-kwWyiag,jgraPEon,https://europepmc.org/articles/PMC5486778/,T cell lymphoma,"lymphoma; NK/TCL, extranodal NK/","; IPI, international prognostic ",TextQuoteSelector,TextPositionSelector,13820,13835,WS_DS,yes,[WS_DS][ALL],,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:42:14.379013+00:00
0ACIFr5LEemORJMVC3xz1A,jgraPEon,https://europepmc.org/articles/PMC5486778/, lung cancer,"ors [9], colorectal cancer [10],"," [11], and other cancer types [1",TextQuoteSelector,TextPositionSelector,10602,10614,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.,2019-08-14T04:27:23.098932+00:00
